document.write("
05\/08\/2025 - Data Integrity in Clinical Trials, AI in Biotech, New FDA Regulations - Quality Digest #210<\/a><\/div>
05\/01\/2025 - Insights on Cleaning Validation, CAPA, Audits, and Automation - Quality Digest #209<\/a><\/div>
04\/24\/2025 - Real-World Evidence, CAPA Management, GxP Systems, Navigating Tariffs, and More - Quality Digest #208<\/a><\/div>
04\/17\/2025 - Remote Auditing Best Practices, Trial Data Overload, Future of Medical Device Labeling, and More \u2013 Quality Digest #207<\/a><\/div>
04\/10\/2025 - Supplier Audit Frequency, FDA 21 CFR Part 11, EU Medical Devices Legislation, and More \u2013 Quality Digest #206<\/a><\/div>
04\/03\/2025 - Risk Management Planning, AI Prompts for SOPs, Post-Market Surveillance, and More \u2013 Quality Digest #205<\/a><\/div>
03\/27\/2025 - CAPA, Top 3 FDA Inspection Issues, DHF vs. DMR vs. DHR, and More \u2013 Quality Digest #204<\/a><\/div>
03\/20\/2025 - Protocol Deviation Puzzle, Combination Products, Key QMS Considerations, and More \u2013 Quality Digest #203<\/a><\/div>
03\/13\/2025 - FDA FY 2024 Warning Letters, Supplier Audits, AI-Driven Decision-Making, and More \u2013 Quality Digest #202<\/a><\/div>
03\/06\/2025 - FDA Inspections, Realities of the Certification Process, AI Copyright Challenges, and More \u2013 Quality Digest #201<\/a><\/div><\/div>");